Publication

Activity of rat cytosolic thioredoxin reductase is strongly decreased by trans-[bis(2-amino-5methylthiazole)tetrachlororuthenate(III)]: First report of relevant thioredoxin reductase inhibition for a ruthenium compound

Mura, P., Camalli, M., Bindoli, A., Sorrentino, F., Casini, A., Gabbiani, C., Corsini, M., Zanello, P., Rigobello, M. P. & Messori, L., 29-Nov-2007, In : Journal of Medicinal Chemistry. 50, 24, p. 5871-5874 4 p.

Research output: Contribution to journalArticleAcademicpeer-review

  • Pasquale Mura
  • Mercedes Camalli
  • Alberto Bindoli
  • Francesca Sorrentino
  • Angela Casini
  • Chiara Gabbiani
  • Maddalena Corsini
  • Piero Zanello
  • Maria Pia Rigobello
  • Luigi Messori

A novel '' Keppler type '' ruthenium(III) compound trans[bis(2-amino 5-methylthiazole)tetrachlororuthenate(III)] 1, of potential interest as an anticancer agent, was designed, synthesized, and characterized. Its interactions with various proteins were analyzed, including the selenoenzyme thioredoxin reductase, an emerging target for anticancer metallodrugs. The selective inhibition of the cytosolic form of this selenoenzyme was documented, this being the first report of significant thioredoxin reductase inhibition by a ruthenium compound.

Original languageEnglish
Pages (from-to)5871-5874
Number of pages4
JournalJournal of Medicinal Chemistry
Volume50
Issue number24
Publication statusPublished - 29-Nov-2007
Externally publishedYes

    Keywords

  • ANTICANCER AGENT, ANTITUMOR DRUGS, NAMI-A, COMPLEXES, IMIDAZOLE, CHEMISTRY, BINDING, CLONING, CELLS

ID: 15011136